Proven Safety of a DES with an Abluminal Biodegradable Polymer
Biodegradable Polymer

Confirmed Safety
- with a 12.3% reduction in MACE compared to the Sirolimus eluting stent at 12 months in LEADERS2
- with no late or very late stent thrombosis in STEALTH I3 out to 4 years
Superior strut coverage at follow up
10 times better strut coverage4 of an abluminal biodegradable polymer BES than a durable symmetric polymer SES
- Abluminal biodegradable polymer BES achieves 96.4% of near to complete strut coverage
Superior stent apposition
More than 20 times better stent apposition4 of an abluminal biodegradable polymer BES than a durable symmetric polymer SES
Biolimus A9™ eluting stent with abluminal biodegradable polymer demonstrates preserved vasomotion5
- A high pacing stimulation induced abnormal vasomotion (vasoconstruction) of the Sirolimus eluting stented vessel when normal vasomotion (vasodilation) was observed in the Biolimus A9™ eluting stented vessel

CAUTION: Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.
Biosensors’ Interventional Cardiology products, including BioMatrix™, Gazelle™, S-Stent™ and Powerline™, are currently not available for sale in the United States.

* Data on file - molecular weight <10kDa


How it works
Watch the working principle of our abluminal biodegradable polymer DES













